CTMX vs CRMD โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
CRMD Captures Institutional Edge (3โ1 Pillars ยท 6โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to CorMedix Inc. (CRMD) driven by superior Valuation, Growth & Margin, Options & Structure while CTMX counters with relative strength in Momentum & Technical. Fundamentally, CTMX trades at 14.2x Forward P/E with -676.4% operating margin (-71.7% YoY revenue) versus CRMD at 49.0x Forward P/E and 41.0% operating margin (-47.7% YoY). In options structure, CTMX sits in BREAKDOWN (60th %ile IV; Dealer Gamma Walls on Pro) against CRMD sits in BREAKDOWN (25th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | CTMX Revenue | CRMD Revenue | CTMX Op. Margin | CRMD Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $60M | $0M | -130.9% | -6250.4% | CTMX |
| FY2019 | $30M | $0M | -525.9% | -7416.3% | CTMX |
| FY2020 | $70M | $0M | -117.7% | -11378.4% | CTMX |
| FY2021 | $40M | $0M | -311.0% | -15417.5% | CTMX |
| FY2022 | $50M | $0M | -190.6% | -46819.9% | CTMX |
| FY2023 | $100M | N/A | -6.4% | N/A | CTMX |
| FY2024 | $140M | $40M | 18.1% | -51.4% | CTMX |
| FY2025 | $80M | $310M | -29.3% | 48.2% | CRMD |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | CTMX | CRMD | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $436.0M | $384.7M | Larger Scale | CTMX |
| Trailing P/E Ratio Valuation | 14.2x | 2.4x | Lower Multiple | CRMD |
| Forward P/E Ratio Valuation | 14.2x | 49.0x | Lower Multiple | CTMX |
| Revenue Growth (YoY) Growth | -71.7% | -47.7% | Higher Growth | CRMD |
| Operating Margin (TTM) Profitability | -676.4% | 41.0% | Higher Margin | CRMD |
| Net Profit Margin Profitability | 0.0% | 15.5% | Higher Margin | CRMD |
| Return on Equity (ROE) Capital Efficiency | -43.5% | 15.3% | Higher ROE | CRMD |
| 52-Week Range Position Momentum | 1% ($2โ$8) | 3% ($5โ$13) | Stronger Trend | CRMD |
| Beta / 30D Volatility Risk Regime | 1.48ฮฒ ยท 78% Vol | 1.20ฮฒ ยท 107% Vol | Lower Realized Risk | CTMX |
| Unified Institutional Score Composite Signal | 53.1 / 100 (HOLD) | 53.2 / 100 (HOLD) | Higher Composite | Tie |